(VIANEWS) – Mercantile Bank Corporation (MBWM), S&T Bancorp (STBA), Devon Energy (DVN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Mercantile Bank Corporation (MBWM)
30% sales growth and 13.6% return on equity
Mercantile Bank Corporation operates as the bank holding company for Mercantile Bank of Michigan that provides commercial and retail banking services for small- to medium-sized businesses and individuals in the United States. It accepts various deposit products, including checking, savings, and term certificate accounts; time deposits; and certificates of deposit. The company also offers commercial, residential mortgage, and instalment loans; vacant land, land development, and residential construction loans; owner and non-owner occupied, and multi-family and residential rental property real estate loans; single-family residential real estate loans; home equity line of credit programs; and consumer loans, such as loans for new and used automobiles, boats, and credit cards, as well as overdraft protection services. In addition, it provides courier services and safe deposit facilities; repurchase agreements; and insurance products, such as private passenger automobile, homeowners, personal inland marine, boat owners, recreational vehicle, dwelling fire, umbrella policies, small business, and life insurance products, as well as owns 27 automated teller machines and 13 video banking machines. The company operates 44 banking offices. Mercantile Bank Corporation was incorporated in 1997 and is headquartered in Grand Rapids, Michigan.
Earnings Per Share
As for profitability, Mercantile Bank Corporation has a trailing twelve months EPS of $2.93.
PE Ratio
Mercantile Bank Corporation has a trailing twelve months price to earnings ratio of 11.77. Meaning, the purchaser of the share is investing $11.77 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.6%.
Sales Growth
Mercantile Bank Corporation’s sales growth is 34.4% for the current quarter and 30% for the next.
2. S&T Bancorp (STBA)
20.1% sales growth and 11.34% return on equity
S&T Bancorp, Inc. operates as the bank holding company for S&T Bank that provides retail and commercial banking products and services. The company operates through six segments: Commercial Real Estate, Commercial and Industrial, Business banking, Commercial Construction, Consumer Real Estate, and Other Consumer. The company accepts time and demand deposits; and offers commercial and consumer loans, cash management services, and brokerage and trust services, as well as acts as guardian and custodian of employee benefits. It also manages private investment accounts for individuals and institutions. In addition, the company distributes life insurance and long-term disability income insurance products, as well as offers title insurance agency services to commercial customers. As of December 31, 2020, it operated 76 banking branches and 5 loan production offices located in Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio, and Upstate New York. S&T Bancorp, Inc. was founded in 1902 and is headquartered in Indiana, Pennsylvania.
Earnings Per Share
As for profitability, S&T Bancorp has a trailing twelve months EPS of $1.01.
PE Ratio
S&T Bancorp has a trailing twelve months price to earnings ratio of 36.87. Meaning, the purchaser of the share is investing $36.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.34%.
Moving Average
S&T Bancorp’s worth is above its 50-day moving average of $35.27 and way higher than its 200-day moving average of $32.35.
Volume
Today’s last reported volume for S&T Bancorp is 64597 which is 60.4% below its average volume of 163162.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 31.1% and 32.4%, respectively.
Yearly Top and Bottom Value
S&T Bancorp’s stock is valued at $37.09 at 01:22 EST, below its 52-week high of $38.43 and way above its 52-week low of $26.51.
3. Devon Energy (DVN)
11.8% sales growth and 63.24% return on equity
Devon Energy Corporation, an independent energy company, primarily engages in the exploration, development, and production of oil, natural gas, and natural gas liquids in the United States. It operates approximately 5,134 gross wells. Devon Energy Corporation was incorporated in 1971 and is headquartered in Oklahoma City, Oklahoma.
Earnings Per Share
As for profitability, Devon Energy has a trailing twelve months EPS of $-7.12.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 63.24%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 26.6% and a drop 3.7% for the next.
Sales Growth
Devon Energy’s sales growth is 4.3% for the current quarter and 11.8% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Dec 8, 2022, the estimated forward annual dividend rate is 5.4 and the estimated forward annual dividend yield is 8.96%.
Moving Average
Devon Energy’s value is way below its 50-day moving average of $59.83 and way under its 200-day moving average of $64.22.
Previous days news about Devon Energy(DVN)
- According to MarketWatch on Monday, 13 March, "Among the more active components, shares of Occidental Petroleum Corp. shed 3.2%, Devon Energy Corp. lost 3.2%, Marathon Oil Corp. slid 3.8%, Exxon Mobil Corp. gave up 2.7% and Chevron Corp. sank 2.9%. "
4. Hexcel Corporation (HXL)
11.2% sales growth and 8.31% return on equity
Hexcel Corporation, together with its subsidiaries, develops, manufactures, and markets structural materials for use in commercial aerospace, space and defense, and industrial markets. It operates through two segments, Composite Materials and Engineered Products. The Composite Materials segment manufactures and markets carbon fibers, fabrics and specialty reinforcements, prepregs and other fiber-reinforced matrix materials, structural adhesives, honeycomb, molding compounds, tooling materials, polyurethane systems, and laminates that are used in military and commercial aircraft, wind turbine blades, recreational products, and other industrial applications, as well as in automotive, marine, and trains. The Engineered Products segment manufactures and markets aircraft structures and finished aircraft components, including wing to body fairings, wing panels, flight deck panels, door liners, rotorcraft blades, spars, and tip caps; and aircraft structural sub-components and semi-finished components used in rotorcraft blades, engine nacelles, and aircraft surfaces, such as flaps, wings, elevators, and fairings. The company sells its products directly through its managers, product managers, and sales personnel, as well as through independent distributors and manufacturer representatives in the Americas, Europe, the Asia Pacific, India, and Africa. Hexcel Corporation was founded in 1946 and is headquartered in Stamford, Connecticut.
Earnings Per Share
As for profitability, Hexcel Corporation has a trailing twelve months EPS of $1.45.
PE Ratio
Hexcel Corporation has a trailing twelve months price to earnings ratio of 47.18. Meaning, the purchaser of the share is investing $47.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.31%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 72.7% and 39.4%, respectively.
5. Badger Meter (BMI)
8.6% sales growth and 15.73% return on equity
Badger Meter, Inc. manufactures and markets flow measurement, quality, control, and communication solutions in the United States, Asia, Canada, Europe, Mexico, the Middle East, and internationally. It offers mechanical or static water meters, and related radio and software technologies and services to municipal water utilities. The company also provides flow instrumentation products, including meters, valves, and other sensing instruments to measure and control fluids going through a pipe or pipeline, including water, air, steam, oil, and other liquids and gases to original equipment manufacturers as the primary flow measurement device within a product or system, as well as through manufacturers' representatives. Its flow instrumentation products are used in water/wastewater, heating, ventilating and air conditioning, and corporate sustainability markets. In addition, the company offers ORION Migratable for automatic meter reading; ORION (SE) for traditional fixed network applications; and ORION Cellular for infrastructure-free fixed network meter reading solution, as well as BEACON advanced metering analytics, a secure cloud-hosted software suite that establishes alerts for specific conditions and allows consumer engagement tools that permit end water customers to view and manage their water usage activity. It also serves water utilities, industrial, and other industries. The company sells its products directly, as well as through resellers and representatives. Badger Meter, Inc. was founded in 1905 and is headquartered in Milwaukee, Wisconsin.
Earnings Per Share
As for profitability, Badger Meter has a trailing twelve months EPS of $2.26.
PE Ratio
Badger Meter has a trailing twelve months price to earnings ratio of 52.69. Meaning, the purchaser of the share is investing $52.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.73%.
6. Amphastar Pharmaceuticals (AMPH)
7.1% sales growth and 16.51% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $0.03.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 1213.67. Meaning, the purchaser of the share is investing $1213.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.51%.
Volume
Today’s last reported volume for Amphastar Pharmaceuticals is 74840 which is 69.59% below its average volume of 246159.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 484.85M for the twelve trailing months.
Sales Growth
Amphastar Pharmaceuticals’s sales growth is 5% for the present quarter and 7.1% for the next.
Yearly Top and Bottom Value
Amphastar Pharmaceuticals’s stock is valued at $36.41 at 01:22 EST, way under its 52-week high of $44.46 and way higher than its 52-week low of $26.76.
Previous days news about Amphastar Pharmaceuticals(AMPH)
- According to Zacks on Tuesday, 14 March, "Some better-ranked stocks from the broader medical sector are Amphastar Pharmaceuticals (AMPH Quick QuoteAMPH – Free Report) sporting a Zacks Rank #1 (Strong Buy) and The Pennant Group (PNTG Quick QuotePNTG – Free Report) and Kiniksa Pharmaceuticals (KNSA Quick QuoteKNSA – Free Report) carrying a Zacks Rank #2 (Buy) at present.", "The bottom line of Amphastar Pharmaceuticals outpaced estimates in all the last four quarters, the average surprise being 35%. "
- According to Zacks on Wednesday, 15 March, "Some better-ranked stocks from the broader medical space are Amphastar Pharmaceuticals (AMPH Quick QuoteAMPH – Free Report) , BioRad Laboratories (BIO Quick QuoteBIO – Free Report) and Catalyst Pharmaceuticals (CPRX Quick QuoteCPRX – Free Report) . "
